Omega-3 fatty acids — primarily EPA and DHA, found in fatty fish and fish-oil supplements — remain one of the most consistently recommended supplements by mainstream medical bodies, and 2026’s renewed interest is really a return to fundamentals after a few years of flashier trends. Per the NIH Office of Dietary Supplements, omega-3s play essential roles in cell membrane structure and are linked in research to cardiovascular and prenatal brain-development outcomes, among other areas of ongoing study.
The NIH fact sheet is also candid about the limits: while omega-3 intake from fish is consistently linked to cardiovascular benefits in observational research, clinical trial results for fish-oil supplements specifically have been more mixed, particularly for people already on cardiovascular medication. Dose, purity, and the ratio of EPA to DHA all affect outcomes, which is part of why product quality varies so much across brands.
For most healthy adults, the NIH considers omega-3 supplementation reasonably safe at typical doses, with the main practical consideration being potential interaction with blood-thinning medication — worth flagging to a doctor if that applies to you.
Official source: NIH Office of Dietary Supplements — Omega-3 Fatty Acids Fact Sheet
This article is for informational purposes only and is not medical advice. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare provider before starting any new supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.